Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...
Reexamination Certificate
2007-07-24
2007-07-24
Landsman, Robert S. (Department: 1646)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Blood proteins or globulins, e.g., proteoglycans, platelet...
C424S139100, C424S145100, C424S152100
Reexamination Certificate
active
10840789
ABSTRACT:
Novel anti-IL-23p40 specific human Ig derived proteins, including, without limitation, antibodies, fusion proteins, and mimetibodies, isolated nucleic acids that encode the anti-IL-23p40 Ig derived proteins, vectors, host cells, transgenic animals or plants, and methods of making and using thereof, are useful for therapeutic compositions, methods and devices. Preferably, the anti-IL-23p40 specific human Ig derived proteins do not bind the p40 subunit of IL-12 and, thus, do not neutralize IL-12-related activity.
REFERENCES:
patent: 6060284 (2000-05-01), Bazan
patent: 6479634 (2002-11-01), Bazan
patent: 6495667 (2002-12-01), Bazan
patent: 6610285 (2003-08-01), Hirata
patent: 6756481 (2004-06-01), Chirica et al.
patent: 6800460 (2004-10-01), Oppmann et al.
patent: 6835825 (2004-12-01), Bazan
patent: 2003/0162261 (2003-08-01), Oppmann et al.
patent: 2004/0223969 (2004-11-01), Oft et al.
patent: 2004/0258686 (2004-12-01), Chirica et al.
patent: 2005/0244874 (2005-11-01), Kastelein et al.
patent: WO 99/05280 (1999-02-01), None
patent: WO 99/40195 (1999-08-01), None
patent: WO 00/09552 (2000-02-01), None
patent: WO 00/53631 (2000-09-01), None
patent: WO 00/70049 (2000-11-01), None
patent: WO 01/18051 (2001-03-01), None
patent: WO 01/85790 (2001-11-01), None
patent: WO 2004/042009 (2004-05-01), None
patent: WO 2004/058178 (2004-07-01), None
patent: WO 2004/071517 (2004-08-01), None
patent: WO 2004/081190 (2004-09-01), None
D'Andrea A., et al. Production of natural killer cell stimulatory factor (Interleukin-12) by peripheral blood mononuclear cells. 1992. J. Exp. Med. vol. 176, pp. 1387-1398.
Peter J. Barnes, “Cytokine-directed therapies for the treatment of chronic airway diseases,” Cytokine & Growth Factor Reviews 14 (2003): 511-522.
Trinchieri, et al., “The IL-12 Family of Heterodimeric Cytokines: New Players in the Regulation of T Cell Responses,” Immunity, 19: 641-644 (2003).
Maguire van Seventer, et al., “Interferon-β differentially regulates expression of the IL-12 family members p35, p40, p19 and EB13 in activated human dendritic cells,” Journal of Neuroimmunology, 133: 60-71 (2002).
Yadav, et al., “Cytokines and autoimmunity: redundancy defines their complex nature,” Current Opinion in Immunology, 15: 697-703 (2003).
Murphy, et al., “Divergent Pro- and Antiinflammatory Roles for IL-23 and IL-12 in Joint Autoimmune Inflammation,” Journal of Experimental Medicine, 198(12): 1951-1957 (2003).
David M. Frucht, “IL-23: A Cytokine That Acts on Memory T Cells,” Science STKE, 114: 1-3 (2002).
Wiekowski, et al., “Ubiquitous Transgenic Expression of the IL-23 Subunit p19 Induces Multiorgan Inflammation, Runting, Infertility, and Premature Death,” Journal of Immunology, 166: 7563-7570 (2001).
Belladonna, et al., “IL-23 and IL-12 Have Overlapping, but Distinct, Effects on Murine Dendritic Cells,” The Journal of Immunology, 168: 5448-5454 (2002).
Parham, et al., “A Receptor for the Heterodimeric Cytokine IL-23 is Composed of IL-12Rβ1 and a Novel Cytokine Receptor Subunit, IL-23R,” The Journal of Immunology, 168: 5699-5708 (2002).
Oppmann, et al., “Novel p19 Protein Engages IL-12p40 to Form a Cytokine, IL-23, with Biological Activities Similar as Well as Distinct from IL-12,” Immunity, 13: 715-725 (2000).
Cua, et al., “Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain,” Nature, 421: 744-748 (2003).
GenBank Accession No. AF301620, Oppmann, et al., Dec. 4, 2000.
GenBank Accession No. AA418955, Hillier, et al., May 12, 1997.
GenBank Accession No. C06368, J. Takeda, Aug. 9, 1996.
GenBank Accession No. AA418747, Hillier, et al., May 12, 1997.
Benson Jacqueline
Cunningham Mark
Centocor, Inc.
Dichter Eric
Hissong Bruce D.
Landsman Robert S.
Townsend Guy Kevin
LandOfFree
IL-23p40 specific antibody does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with IL-23p40 specific antibody, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and IL-23p40 specific antibody will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3816872